Helius Medical Technologies is trading 9.64% higher at $3.18, with no clear company-specific catalyst identified for September 25, 2026.

  • The shares rose from the September 24 close of $2.90.
  • The investor-relations page lists August 21, 2026, as the latest release, with no announcement shown for September 24 or 25.
  • The move remains unexplained and is not attributable to confirmed earnings, regulatory, financing, or corporate news.